The Royal Orthopaedic Hospital NHS Foundation Trust (ROH) is delighted to be partnering with medical technology company, implantcast, to offer a programme of medical education to professionals.
The training will take the shape of surgery observation, with guest consultants invited to attend surgery at the ROH and see procedures performed by the Trust’s specialists up close.
Mr Guy Morris, Consultant Oncology & Arthroplasty Surgeon at the Royal Orthopaedic Hospital said: “The ROH is a leader in treating metastatic bone disease and we have been using implantcast materials for 10 years with really positive patient outcomes.
“There is a drive to improve treatment of bone disease nationally, however this is currently limited by surgeons’ relative inexperience in this type of surgery. We’re over the moon to be able to start offering this programme of surgery observation and education. The aim is for more patients to be treated in their locality and benefit from the service as well as improve patient outcomes for metastatic bone disease nationally.”
Further guidance on metastatic bone disease procedures through lectures will be introduced during the second phase of the education programme. This will include techniques for endoprosthesis insertion (a procedure for replacing a joint in the body that has lost its functionality either through injury or disease in part or whole with an implant).
Adam Dring, General Manager at implantcast UK said: ““implantcast is proud to partner with the Royal Orthopaedic Hospital to deliver a UK-leading training programme for the management of metastatic bone disease. This partnership is testament to the alignment of our goals - to advance healthcare education and make a meaningful impact on improving patient outcomes.
“Together, we aim to set a new standard in line with BOAST guidelines and empower healthcare professionals with the knowledge and skills to provide world-class care for patients affected by metastatic bone disease.”
The Royal Orthopaedic Hospital NHS Foundation Trust is the leading centre for orthopaedic oncology worldwide and is a specialist in metastatic bone cancer. It’s dedicated team of orthopaedic oncology consultants specialise in the diagnosis and treatment of benign and malignant tumours of bone and soft tissues, treating local, national and international patients.
To register your interest for the programme, please contact your local Implantcast representative or email This email address is being protected from spambots. You need JavaScript enabled to view it..
Photo caption: (L-R) Matthew Revell - Executive Medical Director at the Royal Orthopaedic Hospital, Adam Dring – General Manager implantcast UK, Guy Morris - Consultant Oncology & Arthroplasty Surgeon at the Royal Orthopaedic Hospital, and Rachael Campbell – Senior Key Account Manager implantcast UK
